abbott 77003 has been researched along with HIV Coinfection in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boucher, CA; Granneman, R; Ho, DD; Hsu, A; Jurriaans, S; Reedijk, M; Sereni, D; Tzeng, TB; van Bommel, T; Veyssier, P | 1 |
| Erickson, J; Hoekzema, DT; Kageyama, S; Kempf, DJ; Kojima, E; Mitsuya, H; Murakawa, Y; Norbeck, DW; Shirasaka, T | 1 |
| Bilello, JA; Bilello, PA; Drusano, GL; Prichard, M | 1 |
| Amado, RG; Chen, IS; Jamieson, BD; Kaplan, AH; Koka, PS; Withers-Ward, ES; Zack, JA | 1 |
1 trial(s) available for abbott 77003 and HIV Coinfection
| Article | Year |
|---|---|
Safety, pharmacokinetics, and antiviral activity of A77003, a C2 symmetry-based human immunodeficiency virus protease inhibitor.
Topics: Adolescent; Adult; Aged; CD4 Lymphocyte Count; Dose-Response Relationship, Drug; Female; HIV Core Protein p24; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infusions, Intravenous; Leukocytes, Mononuclear; Male; Methylurea Compounds; Middle Aged; Pyridines; RNA, Viral; Valine | 1995 |
3 other study(ies) available for abbott 77003 and HIV Coinfection
| Article | Year |
|---|---|
A C2 symmetry-based HIV protease inhibitor, A77003, irreversibly inhibits infectivity of HIV-1 in vitro.
Topics: Antiviral Agents; Base Sequence; Cell Line; Gene Products, gag; HIV Infections; HIV Protease Inhibitors; HIV-1; Methylurea Compounds; Molecular Sequence Data; Pyridines; RNA, Viral; Valine; Virion; Zidovudine | 1994 |
Modeling combinations of antiretroviral agents in vitro with integration of pharmacokinetics: guidance in regimen choice for clinical trial evaluation.
Topics: Antiviral Agents; Cell Line; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Administration Schedule; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Methylurea Compounds; Models, Biological; Monte Carlo Method; Pyridines; Valine; Zidovudine | 1996 |
Transient renewal of thymopoiesis in HIV-infected human thymic implants following antiviral therapy.
Topics: Animals; Antigens, CD; Antigens, CD34; Antiviral Agents; CD4-Positive T-Lymphocytes; Didanosine; Drug Therapy, Combination; Flow Cytometry; Hematopoietic Stem Cells; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lymphocyte Depletion; Methylurea Compounds; Mice; Mice, SCID; Polymerase Chain Reaction; Proviruses; Pyridines; T-Lymphocytes; Thymus Gland; Transplantation, Heterologous; Valine; Zidovudine | 1997 |